| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Revenues | ||||||
Sales of goods | ||||||
224 | 284 | 253 | ||||
Licensing revenue | ||||||
0 | 0 | 2,509 | ||||
Total revenues | ||||||
224 | 284 | 2,761 | ||||
Operating expenses | ||||||
Research and development | ||||||
7,874 | 6,798 | 8,650 | ||||
Marketing | ||||||
5,428 | 6,175 | 11,602 | ||||
Marketing | ||||||
8 | 7 | 10 | ||||
Cost of sales | ||||||
149 | 173 | 160 | ||||
Total expenses | ||||||
13,459 | 13,153 | 20,422 | ||||
Loss from operations | ||||||
-13,235 | -12,869 | -17,660 | ||||
Net finance income (costs) | ||||||
-194 | -240 | -234 | ||||
Loss attributable to the equity holders | ||||||
-13,429 | -13,110 | -17,894 | ||||
Income tax provision (recovery) | ||||||
0 | 0 | 0 | ||||
Net loss | ||||||
-13,429 | -13,110 | -17,894 | ||||
Net income (loss) per share Basic & Diluted | ||||||
-0.26 | -0.28 | -0.48 | ||||
Weighted average number of common shares outstanding Basic & Diluted | ||||||
52 | 46 | 37 | ||||